BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rutter JL, Bromley CM, Goldstein AM, Elder DE, Holly EA, Guerry D 4th, Hartge P, Struewing JP, Hogg D, Halpern A, Sagebiel RW, Tucker MA. Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study. Cancer. 2004;101:2809-2816. [PMID: 15529312 DOI: 10.1002/cncr.20669] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Casula M, Colombino M, Satta MP, Cossu A, Lissia A, Budroni M, Simeone E, Calemma R, Loddo C, Caracò C, Mozzillo N, Daponte A, Comella G, Canzanella S, Guida M, Castello G, Ascierto PA, Palmieri G; Italian Melanoma Intergroup. Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South Italy. Eur J Cancer 2007;43:137-43. [PMID: 17055252 DOI: 10.1016/j.ejca.2006.07.017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
2 Hübner J, Waldmann A, Eisemann N, Noftz M, Geller AC, Weinstock MA, Volkmer B, Greinert R, Breitbart EW, Katalinic A. Association between risk factors and detection of cutaneous melanoma in the setting of a population-based skin cancer screening. Eur J Cancer Prev 2018;27:563-9. [PMID: 28692584 DOI: 10.1097/CEJ.0000000000000392] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
3 Gold DV, Goggins M, Modrak DE, Newsome G, Liu M, Shi C, Hruban RH, Goldenberg DM. Detection of early-stage pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2010;19:2786-2794. [PMID: 20810605 DOI: 10.1158/1055-9965.epi-10-0667] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
4 Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, Hruban RH. Recent progress in pancreatic cancer. CA Cancer J Clin. 2013;63:318-348. [PMID: 23856911 DOI: 10.3322/caac.21190] [Cited by in Crossref: 479] [Cited by in F6Publishing: 422] [Article Influence: 59.9] [Reference Citation Analysis]
5 Rebours V, Couvelard A, Peyroux JL, Sauvanet A, Hammel P, Ruszniewski P, Lévy P. Familial intraductal papillary mucinous neoplasms of the pancreas. Dig Liver Dis 2012;44:442-6. [PMID: 21824831 DOI: 10.1016/j.dld.2011.07.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
6 Klein AP. Identifying people at a high risk of developing pancreatic cancer. Nat Rev Cancer. 2013;13:66-74. [PMID: 23222481 DOI: 10.1038/nrc3420] [Cited by in Crossref: 90] [Cited by in F6Publishing: 73] [Article Influence: 10.0] [Reference Citation Analysis]
7 Klein AP. Genetic susceptibility to pancreatic cancer. Mol Carcinog. 2012;51:14-24. [PMID: 22162228 DOI: 10.1002/mc.20855] [Cited by in Crossref: 127] [Cited by in F6Publishing: 107] [Article Influence: 14.1] [Reference Citation Analysis]
8 Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol 2021;18:493-502. [DOI: 10.1038/s41575-021-00457-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
9 Fulton AJ, Lamarca A, Nuttall C, McCallum L, Pihlak R, O'Reilly D, Lalloo F, McNamara MG, Hubner RA, Clancy T, Valle JW. Identification of patients with pancreatic adenocarcinoma due to inheritable mutation: Challenges of daily clinical practice. World J Gastrointest Oncol 2019;11:102-16. [PMID: 30788038 DOI: 10.4251/wjgo.v11.i2.102] [Reference Citation Analysis]
10 Patton EE, Mitchell DL, Nairn RS. Genetic and environmental melanoma models in fish. Pigment Cell Melanoma Res 2010;23:314-37. [PMID: 20230482 DOI: 10.1111/j.1755-148X.2010.00693.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
11 Gold DV, Gaedcke J, Ghadimi BM, Goggins M, Hruban RH, Liu M, Newsome G, Goldenberg DM. PAM4 enzyme immunoassay alone and in combination with CA 19-9 for the detection of pancreatic adenocarcinoma. Cancer 2013;119:522-8. [PMID: 22898932 DOI: 10.1002/cncr.27762] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
12 Leachman SA, Carucci J, Kohlmann W, Banks KC, Asgari MM, Bergman W, Bianchi-Scarrà G, Brentnall T, Bressac-de Paillerets B, Bruno W. Selection criteria for genetic assessment of patients with familial melanoma. J Am Acad Dermatol. 2009;61:677.e1-677.14. [PMID: 19751883 DOI: 10.1016/j.jaad.2009.03.016] [Cited by in Crossref: 111] [Cited by in F6Publishing: 64] [Article Influence: 9.3] [Reference Citation Analysis]
13 Amundadottir LT. Pancreatic Cancer Genetics. Int J Biol Sci 2016;12:314-25. [PMID: 26929738 DOI: 10.7150/ijbs.15001] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 12.2] [Reference Citation Analysis]
14 Humphris JL, Biankin AV. Diagnosis and Management of Hereditary Pancreatic Cancer. In: Pichert G, Jacobs C, editors. Rare Hereditary Cancers. Cham: Springer International Publishing; 2016. pp. 61-83. [DOI: 10.1007/978-3-319-29998-3_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
15 Tucker MA. Melanoma epidemiology. Hematol Oncol Clin North Am 2009;23:383-95, vii. [PMID: 19464592 DOI: 10.1016/j.hoc.2009.03.010] [Cited by in Crossref: 95] [Cited by in F6Publishing: 61] [Article Influence: 7.9] [Reference Citation Analysis]
16 Shi C, Hruban RH, Klein AP. Familial pancreatic cancer. Arch Pathol Lab Med. 2009;133:365-374. [PMID: 19260742 DOI: 10.1043/1543-2165-133.3.365] [Reference Citation Analysis]
17 Bernard V, Fleming J, Maitra A. Molecular and Genetic Basis of Pancreatic Carcinogenesis. Surgical Oncology Clinics of North America 2016;25:227-38. [DOI: 10.1016/j.soc.2015.11.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
18 Shi C, Hruban RH, Klein AP. Familial pancreatic cancer. Arch Pathol Lab Med. 2009;133:365-374. [PMID: 19260742 DOI: 10.5858/133.3.365] [Cited by in Crossref: 17] [Cited by in F6Publishing: 68] [Article Influence: 1.4] [Reference Citation Analysis]
19 Grover S, Syngal S. Hereditary pancreatic cancer. Gastroenterology 2010; 139: 1076-1080, 1080.e1-1080. e2. [PMID: 20727885 DOI: 10.1053/j.gastro.2010.08.012] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 5.1] [Reference Citation Analysis]
20 Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, Hruban RH. Recent progress in pancreatic cancer. CA Cancer J Clin. 2013;63:318-348. [PMID: 23856911 DOI: 10.1002/caac.21190] [Reference Citation Analysis]
21 Bishop JN, Harland M, Randerson-moor J, Bishop DT. Management of familial melanoma. The Lancet Oncology 2007;8:46-54. [DOI: 10.1016/s1470-2045(06)71010-5] [Cited by in Crossref: 43] [Cited by in F6Publishing: 9] [Article Influence: 3.1] [Reference Citation Analysis]
22 Segura PP, Ponce CG, Ramón Y Cajal T, Blanch RS, Aranda E. Hereditary pancreatic cancer: molecular bases and their application in diagnosis and clinical management: a guideline of the TTD group. Clin Transl Oncol 2012;14:553-63. [PMID: 22855135 DOI: 10.1007/s12094-012-0840-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]